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Abstract
Nerve Growth Factor (NGF) is a target tissue derived neurotrophin required for normal sympathetic neuron survival and
target tissue innervation. NGF signaling regulates gene expression in sympathetic neurons, which in turn mediates critical
aspects of neuron survival, axon extension and terminal axon branching during sympathetic nervous system (SNS)
development. Egr3 is a transcription factor regulated by NGF signaling in sympathetic neurons that is essential for normal
SNS development. Germline Egr3-deficient mice have physiologic dysautonomia characterized by apoptotic sympathetic
neuron death and abnormal innervation to many target tissues. The extent to which sympathetic innervation abnormalities
in the absence of Egr3 is caused by altered innervation or by neuron death during development is unknown. Using Bax-
deficient mice to abrogate apoptotic sympathetic neuron death in vivo, we show that Egr3 has an essential role in target
tissue innervation in the absence of neuron death. Sympathetic target tissue innervation is abnormal in many target tissues
in the absence of neuron death, and like NGF, Egr3 also appears to effect target tissue innervation heterogeneously. In some
tissues, such as heart, spleen, bowel, kidney, pineal gland and the eye, Egr3 is essential for normal innervation, whereas in
other tissues such as lung, stomach, pancreas and liver, Egr3 appears to have little role in innervation. Moreover, in salivary
glands and heart, two tissues where Egr3 has an essential role in sympathetic innervation, NGF and NT-3 are expressed
normally in the absence of Egr3 indicating that abnormal target tissue innervation is not due to deregulation of these
neurotrophins in target tissues. Taken together, these results clearly demonstrate a role for Egr3 in mediating sympathetic
target tissue innervation that is independent of neuron survival or neurotrophin deregulation.
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Introduction
The sympathetic nervous system (SNS) is a division of the
autonomic nervous system that has essential roles in maintaining
tissue and organ homeostasis. A detailed understanding of the
mechanisms involved in establishing and maintaining normal
sympathetic target tissue innervation is of considerable interest
because abnormal development and degeneration of the SNS is a
component of many human neurological diseases. A variety of
molecules involved in different stages of SNS development have
been identified. For example, migration of neural crest cells from
the margins of the dorsal neural tube, which give rise to
postganglionic sympathetic neurons, is dependent on many
diffusible factors and their cognate receptor signaling including
neuregulin-1/ErbB [1], GFRa3/Ret [2,3] and semaphorin 3a/
neuropilin 1 [4]. In addition, specification of the post-migratory
sympathetic precursors is induced by diffusible factors such as the
bone morphogenetic proteins (BMPs) and a variety of transcrip-
tional regulators including Mash1, Phox2a and b, Hand2 (dHand),
and Gata3 that regulate acquisition of a noradrenergic phenotype
[5,6,7]. To establish connections in the periphery, postganglionic
sympathetic neurons depend on vascular derived diffusible factors
such as Artemin [8] and neurotrophin 3 (NT-3) [9] to guide axons
along blood vessels to reach their targets. One of the most
important target tissue-derived trophic factors is nerve growth
factor (NGF), which is essential for sympathetic neuron survival
and target tissue innervation [10,11].
NGF has been known for many decades to be essential for
sympathetic neuron survival [12,13], but only more recently has a
particularly important role in target tissue innervation also been
appreciated in vivo [10]. For example, loss of NGF with concurrent
loss of the pro-apoptosis molecule Bax, leads to abnormal
sympathetic target tissue innervation in the context of inhibited
neuron death [10], whereas overexpression of NGF in target tissues
leads to hyperinnervation [14,15]. Early NGF signaling events
within sympathetic neurons depend upon binding of NGF to the
TrkA tyrosine kinase receptor and signaling through the Ras/
MAPK pathway to mediate some aspects of NGF-dependent
neuronal differentiation [16,17]. However, very little is known
about how this signaling pathway orchestrates new gene expression
within sympathetic neurons and what role it may have in regulating
axon pathfinding and target tissue innervation in vivo.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25696Egr3 is a transcriptional regulator that is induced in sympathetic
neurons by NGF, its expression is coupled to Ras/MAPK signaling,
and germline Egr3-deficient mice have physiologic dysautonomia
characterized byapoptoticsympatheticneurondeathandabnormal
target tissue innervation [18]. Since sympathetic neuron death
occurs concurrently with abnormal target tissue innervation in
Egr3-deficient mice, it has not been clear to what extent Egr3 has a
direct role in target tissue innervation relative to its role in neuron
survival in vivo. In this study, we examined whether Egr3 has a role
in target tissue innervation using an in vivo context that prevented
sympathetic neuron death. In the absence of the pro-apoptosis
protein Bax, sympathetic neuron death was prevented [19,20] and
mice with simultaneous loss of Bax and Egr3 had atrophic
sympathetic neurons, persistent dysautonomia and sympathetic
target tissue innervation abnormalities. Target tissue innervation
was not effected uniformly, with some tissues showing severe
sympathetic innervation abnormalities, while in other tissues no
innervation abnormalities were observed. These findings are similar
to results obtained in NGF/Bax double knockout mice [10] and are
consistent with previous studies indicating that Egr3 acts as an
effectorofNGFsignalinginsympatheticneuronstomediatenormal
target tissue innervation [18].
Results
Egr3-deficient sympathetic neurons are protected from
death in the absence of Bax
Previous studies demonstrated that approximately 1/3 of
sympathetic neurons die by apoptosis shortly after birth in the
absence of Egr3 and that neuron loss was correlated with
decreased sympathetic target tissue innervation and physiologic
dysautonomia [18]. However, it is not known whether dysauto-
nomia in the absence of Egr3 is due to failure of sympathetic
neurons to properly innervate target tissues, neuron death or a
combination of the two processes. To address whether Egr3 has a
role in target tissue innervation independent of neuron death that
occurs in Egr3-deficient mice, we mated them to Bax knockout
mice [20]. In the absence of the pro-apoptotic protein Bax,
sympathetic neurons are refractory to growth factor-dependent
physiologic death and they do not require neurotrophins, such as
NGF or NT-3 for survival during development [19,21]. Thus, it
was possible to block both Egr3-dependent and physiologic
sympathetic neuron death to ask whether target tissue innervation
is still disrupted in the absence of Egr3. To confirm that
physiologic and Egr3-dependent (pathologic) cell death could be
rescued in mice lacking both Egr3 and Bax (3-B2), we quantified
the number of sympathetic neurons within the SCG from adult
wild type (3+B+), Egr3
2/2; Bax
+/+ (3-B+), Egr3
+/+; Bax
2/2
(3+B2), and Egr3
2/2; Bax
2/2 (3-B2) mice using optical dissector
neuron counting and unbiased stereology. In this genetic
background, 3-B+ mice had approximately 1/3 fewer SCG
neurons compared to wild type (3+B+) mice, similar to previously
published results [18]. Bax-deficient (3+B-) mice had a supra-
physiologic number of SCG neurons compared to wild type
(3+B+) as a consequence of inhibited physiologic death, also in
agreement with previously published results [10] (Fig. 1A).
However, in the absence of both Bax and Egr3 (3-B2), physiologic
and Egr3-dependent neuron loss was inhibited similar to Bax-
Figure 1. Target tissue innervation abnormalities in the absence of sympathetic neuron death in Egr3-deficient mice. (A) In the
absence of the pro-apoptotic molecule Bax, sympathetic neurons in the SCG were protected from both physiologic and Egr3-dependent death.
Approximately 1/3 of SCG neurons were lost in Egr3-deficient (3-B+) compared to wild type (3+B+) mice. In the absence of Bax, physiologic
sympathetic neuron death (3+B2) and Egr3-dependent neuron death (3-B2) was inhibited. Inhibition of physiologic death increased the total
number of SCG neurons as previously reported [10]. (number of SCG analyzed from 8–12 week old mice indicated in parentheses; * = p,0.01 and
n.s.= non-significant compared to 3+B+ mice, Student’s t test) (B) In the absence of Egr3 and inhibited apoptosis (3-B2), SCG neurons were
significantly atrophic. (8–12 week old mice analyzed, * = p,0.001 compared to 3+B2, Student’s t test and size-frequency, x
2,0.0001). (C) Similar
qualitative results were observed in thoracic prevertebral ganglia as apoptotic death was rescued in all sympathetic neurons. Compared to wild type
ganglia (3+B+), 3-B+ ganglia were notably smaller and ganglia lacking Bax, with or without loss of Egr3 were larger. All mice were 8-12 weeks of age
and expressed the DtlZ sympathetic reporter transgene to highlight the ganglia after LacZ histochemical staining (scale bar = 25 mm).
doi:10.1371/journal.pone.0025696.g001
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sympathetic ganglia from mice that also expressed the DtlZ
sympathetic reporter transgene. For example, compared to wild
type (3+B+) ganglia, 3-B+ ganglia were smaller, whereas ganglia
from mice lacking Bax (3+B2 and 3-B2) were notably larger
(Fig. 1C). Thus, loss of Bax protects neurons from death in the
absence of Egr3, similar to the results observed for sympathetic
and sensory neurons that are protected from death by loss of Bax
in the absence of the neurotrophins NGF and NT-3 [10,21].
Target tissue-derived NGF has an essential role in sympathetic
neuron survival and it has a trophic role in their differentiation
and neurite outgrowth during development. In the absence of Bax,
sympathetic neurons do not require NGF for survival, but they
continue to respond to NGF by undergoing cellular hypertrophy
and extending neurites [19,22]. Consistent with our previous
results indicating that Egr3 is a transcriptional effector of NGF
signaling [18], sympathetic neurons devoid of both Bax and Egr3
(3-B2) in vivo were significantly atrophic compared to Bax-
deficient (3+B2) neurons (Fig. 1B) (x
2,0.00001). These results
indicate that Egr3 mediates at least some trophic responses of
sympathetic neurons that are similar to NGF function [10,19].
Sympathetic target tissue innervation abnormalities
persist in Egr3-deficient mice despite inhibited
sympathetic neuron death
In the absence of Bax, it was possible to examine whether Egr3
has a role in sympathetic target tissue innervation independent of
concurrent neuron death. Egr3-deficient mice have blepharoptosis
which is a physiological sign of abnormal sympathetic innervation
from the SCG neurons to the eye and a failure to properly elevate
upper and lower eyelids [18]. We found that blepharoptosis was
Figure 2. Disruption of sympathetic target tissue innervation originating from the SCG in the absence of neuron death in Egr3-
deficient mice. (A) Compared to 8 week old Bax-deficient control mice (3+B2)( B) physiologic ptosis and (B’) innervation abnormalities to the eye
were present in the absence of Egr3 and Bax (3-B2). Results show lacZ staining in mice also expressing the DtlZ sympathetic reporter transgene
which highlighted (B’) superior tarsus muscle innervation (arrowheads) and meibomian gland (arrows) innervation abnormalities to the eyes in 3-B2
mice compared to (A’) 3+B2 control mice. (*=nasal canthus; scale bar=100 mm). (C, C’) Sympathetic innervation to the pineal gland, a major target
of SCG neurons, was reduced by .50% in 3-B2 mice compared to 3+B2 control mice (4–8 weeks old). (scale bar=200 mm)
doi:10.1371/journal.pone.0025696.g002
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in the SCG (Fig. 2A, B). Using DtlZ transgenic reporter mice to
label sympathetic neurons and their innervating axons it was
possible to examine target tissue innervation with high resolution.
Sympathetic innervation to the superior and inferior tarsus
muscles (Fig. 2A’ and B’, arrowheads) and to meibomian glands
on the inner surface of the eyelid (Fig. 2A’ and B’, arrows) were
clearly abnormal in 3-B2 mice (Fig. 2B’) compared to 3+B2 mice
(Fig. 2A’), similar to previous results obtained from Egr3-deficient
mice where there is concurrent sympathetic neuron death [18].
Using tyrosine hydroxylase (TH) immunofluorescence and
semi-quantitative densitometry, we examined target tissue inner-
vation arising from neurons in several sympathetic ganglia. For
example, similar to the eye, sympathetic innervation from the
SCG to the pineal gland was reduced by 55% in the absence of
Egr3 and neuron death (3-B2; Fig. 3C’) compared to Bax-
deficient (3+B2; Fig. 3C) mice. In the heart, where sympathetic
innervation primarily arises from sympathetic neurons within the
para-vertebral stellate ganglion (STG), innervation to the right
(Fig. 3A, A’) and left (Fig. 3B, B’) ventricles was reduced by 58%
and 65%, respectively. Similarly, sympathetic innervation from
pre-vertebral celiac ganglion neurons was markedly decreased in
the glomerular zone (gz) of the renal cortex from 3-B2 mice
compared to 3+B2 mice as demonstrated by the DtlZ transgene
and lacz histochemistry (Fig. 4A, B). Diminished renal cortical
innervation was correlated with a 40% reduction in sympathetic
innervation to the renin-secreting juxtaglomerular apparatus in 3-
B2 relative to 3+B- kidneys (Fig. 4C, D). Sympathetic innervation
to the spleen, which also arises primarily from the pre-vertebral
celiac ganglion, was significantly decreased in 3-B2 relative to
3+B2 mice, whether examined qualitatively with the DtlZ
reporter transgene and lacZ histochemistry (Fig. 5A, B, B’) or
using semi-quantitative TH immunofluorescence to demonstrate a
70% decrease in subcapsular innervation (Fig. 5C, C’).
Sympathetic innervation to the small bowel which arises
primarily from pre-vertebral mesenteric sympathetic ganglia was
also highly disrupted in 3-B2 and 3-B+ relative to 3+B+ mice.
Using TH immunohistochemistry on intact vascularized small
bowel, sympathetic innervation was visualized coursing along the
mesenteric vessels (Fig. 6A, arrowhead) to innervate the bowel wall
(Fig. 6A, arrow). By contrast, innervation to the small bowel in
both 3-B+ and 3-B2 mice appeared to defasciculate and branch
away from the larger blood vessels prior to innervating the bowel
(Fig. 6B, C, arrowheads) and the complex intercrossing pattern of
TH+ fibers within the bowel wall was markedly abnormal (Fig. 6B,
C, arrows). The TH staining pattern in the bowel wall was variable
in different preparations as a result of inqdequate antibody
penetration in some adult tissues. However, the results were
confirmed using LacZ histochemistry and DtlZ+ mice which
showed a markedly attenuated mural pattern of DbH+ fibers in 3-
B2 (Fig. 6E) relative to 3+B- mice (Fig 6D). When the DtlZ
sympathetic reporter transgene was used to examine sympathetic
innervation in to the small bowel in greater detail, more than 50%
of the mucosal villi had no appreciable innervation in 3-B2 mice
(Fig. 6F, G, arrows). In most of the remaining villi, innervation was
detectable but showed highly attenuated branching and decreased
innervation complexity within the villus core (Fig. 6F’, G’).
While many tissues showed significant innervation abnormali-
ties using semi-quantitative TH immunofluorescence and/or
terminal axon staining with the DtlZ reporter transgene in 3-
B2 mice, some tissues such as thymus, lung, stomach, pancreas,
liver and brown fat (Fig. 7) showed no definitive changes in
innervation. In addition, some tissues such as trachea and
esophagus showed only mild innervation abnormalities (Table 1).
Similar heterogeneous effects on sympathetic target tissue
innervation were also previously observed in mice lacking both
NGF and Bax [10].
Target tissue innervation abnormalities are not due to
deregulation of NGF or NT-3 expression in target tissues
in the absence of Egr3
NGF is expressed by target tissues where it is essential for
sympatheticneuron survival and target tissue innervation [11]. NT-3
is expressed in blood vessels along which sympathetic axons travel
Figure 3. Cardiac sympathetic innervation abnormalities in the absence of Egr3 and sympathetic neuron death. Sympathetic
innervation to the (A) right and (B) left ventricles of the heart was reduced by 58% and 65%, respectively in (A’,B ’’) 3-B2 mice compared to (A, B)
3+B2 mice. (scale bar=50 mm) (results of TH immunofluorescence quantification representing the mean 6 standard error; *=p,0.01, Student’s
t test compared to 3+B2 mice; number of 4–8 week old animals analyzed indicated in parentheses).
doi:10.1371/journal.pone.0025696.g003
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early SNS development, primarily through TrkA receptor signaling
[23]. Thus, it is possible that loss of Egr3 in the germline could
deregulatetheexpressionoftheseneurotrophinsintheperipheryand
at least partially explain the sympathetic innervation abnormalities
observed in mice lacking Egr3. However, in the submandibular
gland, an organ that contains very high levels of NGF and robust
sympathetic innervation highly effected by loss of Egr3 [18], there
was no evidence that NGF-b protein levels were altered in 3-
compared to 3+ submandibular glands (Fig. 8A). Similarly, no
changes in the levels of either NGF-b or NT-3 mRNA expression
were identified in submandibular gland (Fig. 8B) or heart which
also receives robust sympathetic innervation that is altered in
Egr3-deficientmice(Fig.8C).Inbothtissues,Egr3wasexpressedat a
verylow levelnearthe detectionthreshold forthe qPCRassay.Thus,
abnormal innervation in Egr3-deficient mice occurs in the context of
normal expression ofNGF and NT-3intarget tissues,indicating that
Egr3 has no role in regulating their expression in the periphery.
Discussion
NGF is produced and released by target tissues where it
mediates sympathetic neuron survival and innervation during
development, a concept that has been clearly established in mice
lacking NGF or its cognate tyrosine kinase receptor TrkA
(NTRK1) [10,11,24]. Egr3 is regulated by NGF/TrkA signaling
Figure 4. Renal sympathetic innervation abnormalities in the absence of Egr3 and sympathetic neuron death. (A, B) Lacz
histochemistry highlighted diffuse renal cortical sympathetic innervation in mice expressing the DtlZ reporter transgene. (B) In the absence of Egr3
and sympathetic neuron death (3-B2;DtlZ) there was a marked decrease in lacZ staining in the glomerular zone (gz) of the renal cortex compared to
(A) control (3+B2;D tlZ) mice. (scale bar=500 mm) (C, D) The decreased sympathetic innervation in the gz was correlated with a 40% reduction of (C,
D) sympathetic innervation (TH immunofluorescence, left) to the renin expressing juxtaglomerular (jg) apparatus (renin immunofluorescence, middle)
within the gz. (scale bar=50 mm) (results of TH immunofluorescence quantification representing the mean 6 standard error in the area juxtaposed to
the jg apparatus; *=p,0.01, Student’s t test compared to 3+B2;D tlZ+ control mice; number of 4–8 week old animals analyzed indicated in
parentheses).
doi:10.1371/journal.pone.0025696.g004
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does not have a direct role in their survival like NGF, it appears to
be required for normal terminal axon extension, branching and
target tissue innervation. Although some sympathetic neurons die
in the absence of Egr3, our current results indicate that neuron
death is a consequence, rather than a cause of abnormal target
tissue innervation. We previously showed that Egr3 does not have
a direct role in sympathetic neuron survival in vitro [18] and here
we demonstrated that when sympathetic neuron death is
prevented in vivo by the absence of the pro-apoptotic protein
Bax, target tissue innervation abnormalities persist in the absence
of Egr3. Although the sympathetic neurons that would otherwise
die in the absence of Egr3 are most likely not normal in the Bax
null genetic background, sensory neurons that lack both TrkA
signaling and Bax are still able to generate limited innervation in
the central nervous system but not to peripheral target tissues [22].
Similar to previous studies with mice lacking both NGF and Bax
[10], we found no evidence that rescue of sympathetic neuron
death in the Bax null background also rescued target tissue
innervation, indicating that any Bax null neurons that would have
otherwise died in the absence of Egr3 were also not competent to
innervate their targets. Thus, persistent abnormal innervation
despite neuron survival indicates that Egr3 has role separate from
neuron survival and that neuron death in vivo is likely a
consequence of inadequate acquisition of target-derived NGF for
a population of sympathetic neurons that have relatively impaired
target innervation. However, since the absence of Egr3 leads to
only partial loss of sympathetic innervation, Egr3 appears to have
a role in regulating the extent of sympathetic target tissue
innervation rather than permitting it to occur. This is consistent
with the observation that Egr3 has no major role in NGF-
dependent neurite outgrowth or branching in vitro (data not
shown) and with our previous in vivo results which indicated that
Egr3 has a role in late stages of SNS development, when terminal
axons are extending and branching within target tissues, rather
than during early axon outgrowth [18].
In similar studies performed using Bax/NGF double
knockout mice or sympathetic neurons isolated from Bax-
deficient mice devoid of NGF treatment in vitro, terminal axon
extension and innervation abnormalities were observed to
differing degrees in target tissues [10] and atrophy due to
decreased neuron metabolism was observed [19], respectively.
We observed strikingly similar abnormalities in Bax/Egr3
double knockout mice which had significant sympathetic
neuron atrophy and heterogeneous effects on sympathetic
innervation to various target tissues. While it is possible that
Egr3 regulates NGF (or NT3) expression in peripheral tissues,
we did not find any evidence that they were abnormally
expressed in the absence of Egr3. Rather, we have previously
suggestedthat Egr3 is an effector of NGF signaling within
sympathetic neurons that regulates essential genes required for
normal tissue innervation. This hypothesis was further support-
ed by this study which showed similar abnormalities present in
the SNS between Bax/NGF and Bax/Egr3 double mutant
mice. However, there were some differences between Bax/NGF
and Bax/Egr3 double knockout mice. For example, in some
tissues such as submandibular gland, parotid gland and heart,
NGF appears to be necessary for target tissue innervation. By
contrast, the absence of Egr3 leads to attenuation of the
innervation to these organs rather than complete loss. Similarly,
in some tissues such as thymus, lung, stomach and liver, NGF
appears to have a major role in their innervation, whereas Egr3
does not. These discrepancies could reflect that Egr3 is just one
of a number of effectors of NGF signaling and therefore it could
have a relatively restricted function in a sub-population of
NGF-dependent neurons. In addition, Bax/NGF knockout
Figure 5. Abnormal innervation to the spleen in the absence of Egr3 and sympathetic neuron death. (A) Sympathetic innervation to the
spleen was highly diminished in Egr3-deficient mice (3-B2;D tlZ+) compared to control (3+B2;D tlZ+) mice. Note the markedly decreased lacZ
reaction product in the Egr3-deficient spleen (right compared to left) which correlated with decreased subcapsular (B’) lacZ reaction (arrows) and (C’)
TH+ terminal axon innervation in Egr3-deficient mice (3-B2;D tlZ+) relative to (B, C) control (3+B2;D tlZ+) mice. In Egr3-deficient spleens
sympathetic innervation was reduced by .70%. (results of TH immunofluorescence quantification representing the mean 6 standard error from 3 4–
8 week old mice of each genotype; *=p,0.0001, Student’s t test; scale bar=A, 1 mm; B, B’, 0.5 mm; C, C’, 10 mm).
doi:10.1371/journal.pone.0025696.g005
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(3+B+) mice, tyrosine hydroxylase (TH) immunohistochemistry performed on vascularized intact small bowel demonstrated sympathetic axons
coursing along the mesenteric blood vessels (arrowhead) and prominent intercrossing pattern of TH+ fibers in the bowel wall (arrow). (B, C)I n
preparations from mice lacking Egr3, with (3-B+) our without Bax (3-B2), the TH+ axons were noted to prematurely defasciculate from the mesenteric
blood vessels prior to innervating the bowel wall (arrowhead) and the pattern of intercrossing TH+ fibers in the bowel wall was highly attenuated
(arrow) (4 week old mice shown). (D, E) The attenuated mural innervation was confirmed using DtlZ sympathetic reporter mice which showed a
highly attenuated innervation of the bowel wall in 3-B2 relative to 3+B2 mice. (F) Sympathetic innervation to the small bowel mucosa was observed
in the vascular core of mucosal villi from control (3+B2;D tlZ+) sympathetic reporter mice (arrow, villi shown in whole mount preparation in the axial
plane). (F’) Sympathetic innervation within the small bowel villi paralleled the vascular capillary network (villus shown in whole mount preparation in
the longitudinal plane). (G) In Egr3-deficient mice with inhibited sympathetic neuron death (3-B2;D tlZ+) ,45% of the villi were innervated (arrow)
and (G’) most villi that did have some innervation showed a highly attenuated abnormal innervation pattern. (quantitative results represent the mean
6 standard error of .500 villi scored; *=p,0.01, Student’s t test compared to 3+B2;D tlZ+ control mice; scale bar=50 mm; number of 4–8 week old
animals analyzed indicated in parentheses).
doi:10.1371/journal.pone.0025696.g006
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making it impossible to rule out developmental delay as a cause
of the discrepancies or to study the end-stage target tissue
innervation phenotypes in adult animals as we did for Bax/Egr3
knockout mice. Nevertheless, considering previous studies
showing that Egr3 is regulated by NGF signaling in sympathetic
neurons, it is reasonable to conclude that Egr3 modulates
gene expression required for at least some aspects of NGF-
mediated sympathetic terminal axon extension and target tissue
innervation [18].
Currently, the specific target genes regulated by Egr3 during
sympathetic target tissue innervation are not known. One clue
related to the mechanisms of Egr3 action in sympathetic neurons
may come from the observation that axons prematurely
defasciculate from the major mesenteric vessels as they innervate
the bowel in the absence of Egr3. Perhaps genes that regulate
axon fasciculation and/or axon guidance along blood vessels
may be involved. This seems plausible as axon guidance
molecules expressed by neurons such as neuropilin-1 (npn1)
have a major role in axon fasciculation and target tissue
innervation patterning [25]. Future studies will be required to
identify the precise target genes regulated by Egr3 to better
understand how it participates in orchestrating NGF signaling
during target tissue innervation.
NGF has an essential role in regulating sympathetic neuron
target tissue innervation that is in part regulated by Egr3.
Although the current results indicate that Egr3 does not regulate
NGF or NT-3 in peripheral tissues, it has not been formally
demonstrated that Egr3 has its primary function within sympa-
thetic neurons to impact their target tissue innervation. A formal
proof that Egr3 has an essential role in regulating target gene
expression within sympathetic neurons to mediate target tissue
innervation, and potentially to maintain innervation homeostasis,
will require more sophisticated genetic studies to demonstrate its
sympathetic neuron autonomous function.
Figure 7. Normal sympathetic innervation was observed in
some tissues in the absence of Egr3 and neuron death. In brown
fat for example, which receives dense sympathetic innervation to
regulate thermogenesis no definitive changes were observed in (A)
3+B2 relative to (B) 3-B2 mice. (scale bar =100 mm).
doi:10.1371/journal.pone.0025696.g007
Table 1. Target tissue innervation in 3-B2 mice compared to
3+B2 mice.
Heart + (p,0.001)
Spleen + (p,0.001)
Distal Ileum + (p,0.001)
Eyelid (tarsus muscles and meibomian glands) +
Pineal Gland ++ (p,0.001)
Kidney ++ (p,0.001)
Trachea +++
Esophagus +++
Sympathetic chain ganglia +++
Intercostal nerves (proximal projections) +++
Thymus ++++
Lung ++++
Stomach ++++
Pancreas (head) ++++
Liver ++++
Brown fat ++++
+ = highly reduced innervation relative to adult 3+B2 control mice.
+++ and ++ = intermediate innervation relative to adult 3+B2 control mice.
++++ = similar innervation relative to adult 3+B2 control mice.
p values, Student’s t test, from semi-quantitative TH immunofluorescence.
doi:10.1371/journal.pone.0025696.t001
Figure 8. Normal NGF and NT-3 expression in two target tissues with markedly abnormal sympathetic innervation in Egr3-deficient
mice. (A) Western blotting for NGF and actin (loading control) showed that NGF protein levels were similar in submandibular glands between wild
type (3+) and Egr3-deficient (3-) mice (submandibular gland protein lysates from two different newborn mice shown). qPCR to measure the level of
NGF and NT-3 transcript expression in (B) submandibular gland and (C) heart showed no significant differences between 3+ and 3- mice. Egr3
expression in both tissues was low and near detection threshold. (results represent the mean 6 standard error of tissues from 3–4 animals 8–10
weeks old of each genotype; n.s. = non-significant, Student’s t test).
doi:10.1371/journal.pone.0025696.g008
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Ethics statement
All experiments with animals reported complied with relevant
national and international guidelines. All experimental procedures
involving mice complied with a animal studies protocol (#2009-
1886) approved by the Northwestern University Institutional
Animal Care and Use Committee (IACUC) and PHS animal
welfare assurance to Northwestern University (#A3283-01).
Animals
Mice with a germline deletion of Egr3 (Egr3
2/2) and Bax (Bax
2/2)
were previously described and backcrossed .5 generations into the
C57BL/6J isogenic background [20,26]. The DbH-tlacZ (DtlZ)
sympathetic reporter transgenic mice, which express axon localized
b-galactosidase (tlacZ) in noradrenergic neuron (including sympa-
thetic neurons) were generated on a B6SJL genetic background and
backcrossed .4 generations into the C57BL/6J isogenic background
as previously described [18].
Genotyping was performed by PCR using genomic DNA
isolated from tail biopsy tissue. The sequences of the genotyping
primers and PCR conditions are available upon request.
Adolescent and adult mice (4–20 weeks old) were used for all
analyses with the exception that newborn mice were used to obtain
protein lysates from submandibular gland for Western blotting.
For most experiments littermate or age-matched wild type mice
were used as control. In experiments using Egr3/Bax double
knockout (3-B2) mice, littermate mice lacking only Bax expression
(3+B2) were used as control to examine the effects of loss of Egr3
on SNS development in the context of inhibited neuron death
[19]. Three or more animals per genotype were analyzed per
experimental condition as indicated.
Tissue preparation
Anesthetized mice were perfused through the heart with 0.1 M
phosphate buffered (pH=7.2) 4% paraformaldehyde (PFA) and
tissues were post-fixed at 4uC for 1–4 hours. Some tissues were
cryoprotected overnight at 4uC in graded (15–30%) sucrose,
embedded in OCT and 12 mm frozen sections were analyzed. For
some experiments, tissues were isolated fresh for protein and/or
RNA isolation. For quantitative studies involving neuron counts
and morphometry, PFA fixed tissues were embedded in paraffin
and serial sectioned at 16 mm.
Ganglion neuron counts and evaluation of neuron soma
area
SCG neuron numbers from 8–12 week old Egr3
+/+; Bax
+/+
(3+B+), Egr3
2/2; Bax
+/+ (3-B+), Egr3
+/+; Bax
2/2 (3+B2), and
Egr3
2/2; Bax
2/2 (3-B2) mice were determined using unbiased
stereology and optical dissector methods (StereoInvestigator,
Microbrightfield, Williston, VT) on every fifth serial section as
previously described [18,27]. Neurons within randomly selected
stereologic counting frames in the SCG with clear nuclear and
nucleolar profiles were analyzed. SCG neuron soma area was
estimated using Metamorph software (Molecular Devices, Sunny-
vale, CA) on calibrated digital photomicrographs. Neurons from
multiple sections throughout the rostral-caudal extent of the SCG
were counted and the soma area of .300 neurons per genotype
was measured.
Immunohistochemistry
Immunofluorescence staining for tyrosine hydroxylase (TH;
sheep anti-TH, 1:5000 Chemicon) to identify sympathetic
terminal axon innervation and Renin (goat anti-renin, 1:1000
Santa Cruz) to identify the juxtaglomerular apparatus in kidney
was performed on frozen tissue sections. A secondary antibody
conjugated with Cy3 (Jackson Immunoresearch) or Alexa-488
(Invitrogen) was used to localize primary antibody binding. In
some experiments tissues were stained intact without sectioning
using TH primary antibody and immunoperoxidase detection as
previously described [3]. In all experiments, non-immune serum
was used in place of the primary antibody to control for non-
specific antibody binding.
Western Blotting
Western blotting was performed as previously described [28].
Primary antibodies to detect b-NGF (Sigma, N6655, 1:1000) and
actin (Santa Cruz, sc-1616, 1:1000) were used with HRP-
conjugated secondary antibodies (Jackson Immunoresearch) and
enhanced chemiluminescence (ECL) detection (Amersham) on
total cellular protein isolated from Egr3
+/+ (3+) and Egr3
2/2 (3-)
newborn (P0) submandibular glands.
Semi-quantitative sympathetic axon terminal innervation
Quantification of target tissue innervation was performed using
fluorescence densitometry: Fluorescent images were captured with
a Zeiss LS510 confocal microscope using identical aperture and
photomultiplier tube voltage settings to ensure accurate compar-
ison between tissues from 3+B- and 3-B- mice. The density of TH-
positive terminals was calculated using MetaMorph software as the
ratio of total immunofluorescence in a specified area and averaged
for 6 separate confocal frames at 200x total magnification.
Representative sympathetic target tissues, such as heart (left and
right ventricles), distal ileum, trachea, esophagus, stomach,
thymus, pineal gland, lung, pancreas, liver, spleen and kidney
were analyzed in areas with the highest density of axons identified
in control (3+B2) tissues. The ‘‘relative innervation’’ in 3-B2 mice
was expressed as a mean percent of control (3+B2) from 3–8
animals of each genotype as indicated.
LacZ enzyme histochemistry
Whole mount lacZ enzyme histochemistry of periorbital tissue,
SCG, kidney, spleen and distal ileum from 4–8 week old 3+B2
and 3-B2 mice that also carried the DtlZ sympathetic reporter
transgene was performed as previously described [18]. Innervation
to intestinal villi from similar portions of the distal ileum was
quantified in 3+B2;DtlZ+ and 3-B2;DtlZ+ mice. The adventitia
and deep muscularis was removed from the lacZ stained ilea and
the mucosal surface was photographed using a Nikon E600
microscope and digital camera (RT-Slider, Diagnostic Instru-
ments, Sterling Heights, MI). For each genotype, .500 villi were
scored to determine whether they contained innervation or not
based upon visualization of lacZ reaction product within each
villus core. Villi containing any identifiable innervation were
scored as ‘‘innervated’’ and those without visible innervation were
scored as ‘‘non-innervated.’’ The results were reported as the
mean % of innervated villi compared to the total number of villi
examined from 3 mice of each genotype.
Semi-quantitative real-time PCR (qPCR)
qPCR was performed as previously described in detail [27].
Briefly, total cellular RNA was isolated from wild type 8–10 week
old SCG and two sympathetic target tissues, submandibular gland
and heart. cDNA was synthesized using Superscript III reverse
transcriptase (Invitrogen) and random octomer/oligo-dT priming
according to recommendations by the manufacturer. Relative
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fluorescence with non-intron spanning primers. Standard curves
were generated for each primer pair using mouse genomic DNA
and the target gene expression results were normalized to GAPDH
expression for each sample analyzed. The results were expressed
either as unitless expression relative to GAPDH or fold-change
expression relative to control tissue. Oligonucleotide primers
amplified the following nucleotide sequences: GAPDH: (Genbank
NM_008084, nt 202–627), NGF: (Genbank NM_013609, nt 604–
904), NT-3: (Genbank NM_008742, nt 446–846) and Egr3:
(Genbank NM_018781, nt 163–563).
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